Aims and scope
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.
Articles
Vulvar lichen sclerosus oncologic risk: italian interdisciplinary Society of Vulvology (SIIV) Position Paper
Vulvar lichen sclerosus oncologic risk: italian interdisciplinary Society of Vulvology (SIIV) Position Paper
DOI: 10.22514/ejgo.2022.006
Circulating tumor cells in metastatic breast cancer: ready for clinical practice?
Circulating tumor cells in metastatic breast cancer: ready for clinical practice?
DOI: 10.22514/ejgo.2022.007
(This article belongs to the Special Issue Breast Cancer)
Surgical management in the pelvis for patients with advanced ovarian cancer
Surgical management in the pelvis for patients with advanced ovarian cancer
DOI: 10.22514/ejgo.2022.003
(This article belongs to the Special Issue Radical Surgery in Ovarian Cancer)
Germline multigene panel testing in gynecological cancer
Germline multigene panel testing in gynecological cancer
DOI: 10.22514/ejgo.2022.008
(This article belongs to the Special Issue Gynecological Oncology Treatment: Recent Progress in Clinical Modalities)
Management of nodal disease in advanced-stage ovarian cancer: porta hepatis, celiac, pelvic and paraaortic lymphadenectomy
Management of nodal disease in advanced-stage ovarian cancer: porta hepatis, celiac, pelvic and paraaortic lymphadenectomy
DOI: 10.22514/ejgo.2022.009
(This article belongs to the Special Issue Radical Surgery in Ovarian Cancer)
Efficacy and safety of olaparib in the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review and meta-analysis
Efficacy and safety of olaparib in the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review and meta-analysis
DOI: 10.22514/ejgo.2022.010
Diaphragmatic resection and liver mobilization during surgery for advanced ovarian cancer
Diaphragmatic resection and liver mobilization during surgery for advanced ovarian cancer
DOI: 10.22514/ejgo.2022.011
(This article belongs to the Special Issue Radical Surgery in Ovarian Cancer)
Advances of exosomes in the cervical cancer
Advances of exosomes in the cervical cancer
DOI: 10.22514/ejgo.2022.012
(This article belongs to the Special Issue Cervical Cancer and Novel Interventions)
Inquiry and Endometrial-Online computer program: 27 years of clinical registry for endometrial cancer at the University Medical Centre Maribor
Inquiry and Endometrial-Online computer program: 27 years of clinical registry for endometrial cancer at the University Medical Centre Maribor
DOI: 10.22514/ejgo.2022.001
(This article belongs to the Special Issue Endometrial Cancer)
Systemic therapy is effective in the management of leiomyomatosis
Systemic therapy is effective in the management of leiomyomatosis
DOI: 10.22514/ejgo.2022.013
(This article belongs to the Special Issue Rare Gynecological Malignancies)
Short and long-term outcomes of endometrial cancer and atypical endometrial hyperplasia management in young women
Short and long-term outcomes of endometrial cancer and atypical endometrial hyperplasia management in young women
DOI: 10.22514/ejgo.2022.004
(This article belongs to the Special Issue Endometrial Cancer)
Association of anemia and neutrophil-lymphocyte ratio with overall survival in breast cancer patients
Association of anemia and neutrophil-lymphocyte ratio with overall survival in breast cancer patients
DOI: 10.22514/ejgo.2022.014
(This article belongs to the Special Issue Prognosis and Treatment of Breast Cancer)
Pretreatment anemia status and elevated PLR affect the prognosis of locally advanced cervical squamous cell carcinoma patients treated with concurrent chemoradiotherapy
Pretreatment anemia status and elevated PLR affect the prognosis of locally advanced cervical squamous cell carcinoma patients treated with concurrent chemoradiotherapy
DOI: 10.22514/ejgo.2022.005
Improving the mortality index among gynecologic oncology patients
Improving the mortality index among gynecologic oncology patients
DOI: 10.22514/ejgo.2022.015
(This article belongs to the Special Issue Gynaecological Oncology: Challenges for the 21st Century)
Tumour mutational burden and immune-cell infiltration in cervical squamous cell carcinoma
Tumour mutational burden and immune-cell infiltration in cervical squamous cell carcinoma
DOI: 10.22514/ejgo.2022.016
Clinical and pathological examination of 11 cases of ovarian seromucinous tumor at our institute
Clinical and pathological examination of 11 cases of ovarian seromucinous tumor at our institute
DOI: 10.22514/ejgo.2022.017
(This article belongs to the Special Issue Gynecological Oncology Treatment: Recent Progress in Clinical Modalities)
18 Sertoli-leydig cell tumors of the ovary: analysis of a single institution database
18 Sertoli-leydig cell tumors of the ovary: analysis of a single institution database
DOI: 10.22514/ejgo.2022.018
(This article belongs to the Special Issue Rare Gynecological Malignancies)
Carcinoma arising within phyllodes tumors of the breast: clinicopathologic observation and a literature review of five cases
Carcinoma arising within phyllodes tumors of the breast: clinicopathologic observation and a literature review of five cases
DOI: 10.22514/ejgo.2022.019
Successful management of metastatic ovarian carcinosarcoma with olaparib plus bevacizumab: a case report
Successful management of metastatic ovarian carcinosarcoma with olaparib plus bevacizumab: a case report
DOI: 10.22514/ejgo.2022.002
Cervical villoglandular adenocarcinoma: a rare case report and review of the literature
Cervical villoglandular adenocarcinoma: a rare case report and review of the literature
DOI: 10.22514/ejgo.2022.020
Published Ahead of Print
A rare case of pseudomyxoma peritonei caused by borderline mucinous tumor arising from primary mature cystic ovarian teratoma
A rare case of pseudomyxoma peritonei caused by borderline mucinous tumor arising from primary mature cystic ovarian teratoma
Online publish date: 22 June 2022
DOI: 10.22514/ejgo.2022.022
Review of neoadjuvant chemotherapy characteristics in advanced epithelial ovarian cancer: experience from two cancer centers
Review of neoadjuvant chemotherapy characteristics in advanced epithelial ovarian cancer: experience from two cancer centers
Online publish date: 15 June 2022
DOI: 10.22514/ejgo.2022.021
Special Issues
Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"
Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors
Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD
Submission deadline: 31 December 2022
Breast Cancer
Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment
Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD
Submission deadline: 30 April 2022
Systematic Review or Meta-Analysis in Gynaecological Oncology
Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer
Editor: Enrique Hernandez, MD
Submission deadline: 25 April 2022
Prognosis and surgical treatment of Endometrial Cancers
Keywords: Endometrial Cancer; Endometrial Biopsy; Debulkyng Surgery; Fertility Preservation; High-Risk Factors
Editor: Nicolae Gica, MD, PhD
Submission deadline: 28 June 2023
Prognostic Models Based on Machine Learning for Gynecological Cancers
Keywords: Bioinformatics; Machine Learning; Signature; Prognostic Models; Gynecological Cancers
Editor: Feng Jiang, MD
Submission deadline: 31 January 2023
Advanced Decision Support Systems for Efficient Diagnosis of Gynaecological Cancers
Keywords: Computational and Mathematical Methods; Gynaecological Cancers; Machine Learning; Optimization Algorithms
Editor: Liaqat Ali, PhD
Submission deadline: 31 October 2022
Polycystic Ovary Syndrome and the Risk of Endometrial Cancer
Keywords: PCOS; Endometrial Hyperplasia; Endometrial Cancer; Unopposed Estrogen Effect; Progesterone Resistance; Endometrial Mesenchymal Stroma/Stem Cells; Obesity; Insulin Resistance; Hyperandrogenism; Inflammation
Editor: Masuma Khatun, PhD
Submission deadline: 24 June 2023
Biotechnologies, Imaging Modalities and Analysis Methodologies for Probing the Breast Cancer
Keywords: Breast Cancer; Imaging; Biotechnology; Data Analysis
Editor: Yu Shang, PhD,Shun Wan Chan, PhD
Submission deadline: 01 June 2023
Biomarkers for Gynaecological Cancers Diagnosis and Treatment Selection from Basic Research to Practice
Keywords: Gynaecological Cancers; Biomarkers; Diagnosis; Prognosis; Targeted Therapy
Editor: Wenwen Zhang, MD, PhD,Xiaoxiang Guan, MD, PhD,Xiaowei Wei, MD, PhD
Submission deadline: 01 July 2023
New Molecular Approaches for Comprehensive Management of Gynaecological Oncology
Keywords: Gynaecological Oncology
Editor: Prof. Linli Wu, PhD
Submission deadline: 31 January 2023
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.